Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Collaboration between ICR and NEOsphere set to transform cancer research with next-generation molecular glue technologies

(IN BRIEF) The Institute of Cancer Research and NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of…

13 hours ago

Labomar acquires Finland-based Pharmia Holding Oy from CapMan to strengthen European probiotics and medical devices portfolio

(IN BRIEF) CapMan Buyout has sold Pharmia Holding Oy, the leading Nordic contract manufacturer of dietary supplements and medical devices,…

1 day ago

New Liverpool-led biosensors with AI offer low-cost solution for Alzheimer’s diagnosis worldwide

(IN BRIEF) Scientists at the University of Liverpool have developed two new handheld blood test devices that could make Alzheimer’s…

3 days ago

Tender Offer for Tourmaline Bio Shares Launched by Novartis Subsidiary Torino Merger Sub

(IN BRIEF) Novartis, through its wholly owned subsidiary Torino Merger Sub Inc., has launched a tender offer to acquire all…

4 days ago

Cosentyx Becomes First Novartis Medicine Offered at 55% Discount Through New DTP Model

(IN BRIEF) Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which…

4 days ago

University of Exeter and Royal Devon NHS Launch Study to Cut Delays in Diagnosing Crohn’s and Colitis

(IN BRIEF) The Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter have launched the RAPID-IBD study…

4 days ago

The Institute of Cancer Research study reveals breakthrough approach to treating deadly pancreatic cancer

(IN BRIEF) The Institute of Cancer Research, London, has uncovered a promising new treatment target for pancreatic cancer, identifying the…

1 week ago

AstraZeneca and Daiichi Sankyo’s Enhertu-based regimen shows 44% risk reduction and over three-year PFS in HER2-positive metastatic breast cancer

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review…

1 week ago